Fund profile
Tickers
SANE
Fund manager
Total assets
$573.07 k
Liabilities
$2.95 k
Net assets
$570.12 k
Number of holdings
26.00
SANE stock data
26 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ProShares UltraPro Short QQQ
|
51.84 k | 2.54 k shares | 9.09 | Common equity | Long | USA |
Asics Corp
|
28.73 k | 822.00 shares | 5.04 | Common equity | Long | Japan |
Novartis AG
|
28.41 k | 277.00 shares | 4.98 | Common equity | Long | Switzerland |
WST West Pharmaceutical Services, Inc. | 27.77 k | 74.00 shares | 4.87 | Common equity | Long | USA |
AAPL Apple Inc | 27.39 k | 160.00 shares | 4.80 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 27.16 k | 33.00 shares | 4.76 | Common equity | Long | USA |
Puma SE
|
26.79 k | 431.00 shares | 4.70 | Common equity | Long | Germany |
GSK GSK Plc | 25.67 k | 708.00 shares | 4.50 | Common equity | Long | UK |
adidas AG
|
24.84 k | 141.00 shares | 4.36 | Common equity | Long | Germany |
UTHR United Therapeutics Corp | 24.62 k | 109.00 shares | 4.32 | Common equity | Long | USA |
BIIB Biogen Inc | 24.16 k | 94.00 shares | 4.24 | Common equity | Long | USA |
MRK Merck & Co Inc | 23.58 k | 229.00 shares | 4.14 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 22.33 k | 874.00 shares | 3.92 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 21.49 k | 40.00 shares | 3.77 | Common equity | Long | USA |
ALKS Alkermes plc | 21.37 k | 763.00 shares | 3.75 | Common equity | Long | Ireland |
CBAY Cymabay Therapeutics Inc | 20.96 k | 1.41 k shares | 3.68 | Common equity | Long | USA |
SAN Banco Santander S.A. | 17.38 k | 162.00 shares | 3.05 | Common equity | Long | France |
Otsuka Holdings Co Ltd
|
16.89 k | 475.00 shares | 2.96 | Common equity | Long | Japan |
SNY Sanofi | 16.15 k | 301.00 shares | 2.83 | Common equity | Long | France |
Eisai Co Ltd
|
15.00 k | 270.00 shares | 2.63 | Common equity | Long | Japan |
AZN Astrazeneca plc | 14.70 k | 217.00 shares | 2.58 | Common equity | Long | UK |
OLMA Olema Pharmaceuticals Inc | 13.93 k | 1.13 k shares | 2.44 | Common equity | Long | USA |
DVA DaVita Inc | 11.72 k | 124.00 shares | 2.06 | Common equity | Long | USA |
NVO Novo Nordisk | 11.46 k | 126.00 shares | 2.01 | Common equity | Long | Denmark |
ANIP ANI Pharmaceuticals Inc | 11.32 k | 195.00 shares | 1.99 | Common equity | Long | USA |
ROG Rogers Corp. | 10.12 k | 37.00 shares | 1.78 | Common equity | Long | Switzerland |